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Nipah Virus (NiV) is an emerging infectious 
disease which first surfaced in domestic pigs in 
Malaysia and Singapore in the 1998/9. There is 
evidence of Nipah infection among several 
species of domestic animals including dogs, 
cats, goats, and horses. Sheep may also be 
affected. However, since the initial outbreak it 
has primarily affected humans in different parts 
of the world. The disease causes respiratory and 
sometimes nervous signs in pigs. It has 
disastrous zoonotic potential. 
The organism which causes Nipah Virus 
encephalitis is an RNA virus of the family 
Paramyxoviridae, genus Henipavirus, and is 
closely related to Hendra virus. Hendra virus, 
formerly known as equine morbillivirus 
pneumonia or acute equine respiratory 
syndrome, is an acute, viral respiratory infection 
of horses and humans that has been reported in 
Australia. Nipah Virus infection, also known as 
Nipah Virus encephalitis, was first isolated and 
described in the year 1999. The name, Nipah, is 
derived from the village in Malaysia where the 
person from whom the virus was first isolated 
surrender to the disease. 
In January and February of 2001, an outbreak of 
febrile illness with altered sensorial was 
observed in Siliguri, West Bengal, India. Siliguri 
is an important commercial center with an 
approximate population of 500,000. Sharing 
borders with China, Bangladesh, Nepal, and 
Sikkim. The outbreak occurred among 
hospitalized patients, family contacts of the 
patients, and medical staff of 4 hospitals. Nipah 
virus (NiV), a recently emergent, zoonotic 
paramyxovirus was implicated as the cause of a 
highly fatal (case-fatality ratio 38%–75%), 
febrile humanencephalitis in Malaysia and 
Singapore in 1999 [1]. Bangladesh during the 
winters of 2001, 2003, and 2004 [3-6]. 
The natural reservoir of NiV is presumed to be 
fruit bats of the genus Pteropus. Evidence of 
NiV infection wasdetected in these bats in 
Malaysia, Bangladesh, and Cambodia.[7-10] In 
the Malaysian outbreak, NiV was introduced 
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into the pig population, and most of the human 
cases resulted from exposure to ill pigs.[2] 
Thus, Nipah virus is an enveloped, non-
segmented, negative strand RNA virus. Six 
structural proteins are encoded by the Nipah 
virus genome: the nucleoprotein N, 
phosphoprotein P, matrix protein M, the two 
envelope glycoproteins F (fusion) and G 
(receptor binding) and the RNA-dependent RNA 
polymerase L [11]. 
Serological and virus detection studies have 
found evidence for Nipah virus infection in 
multiple flying fox species, such as the island 
flying fox (Pteropushypomelanus), the Malayan 
flying fox (Pteropusvampyrus), the Indian flying 
fox (Pteropusgiganteus) and Lyle's flying fox 
(Pteropuslylei) [11]. 
History of cases detection background 
NiV infection has not been detected in Malaysia 
or Singapore after 1999, but recurring (almost 
annual) human cases of Nipah encephalitis with 
very high case fatalities in Bangladesh and 
sporadic outbreaks in India since 2001 (Table1) 
 
Table 1. Morbidity and mortality in humans due to NiV, India–Bangladesh [12, 13] D. D. Kulkarni et 
al. 






Jan–Feb 2001 Siliguri (India)  66 45 68 
Apr–May 
2001 
Meherpur (Bangladesh) 13 9 69 
Jan 2003 Naogaon (Bangladesh) 12 8 67 
Jan 2004 Rajbari(Bangladesh 31 23 74 
Apr 2004  Faridpur (Bangladesh) 36 27 75 
Jan–Mar 2005 Tangail (Bangladesh) 12 11 92 
Jan–Feb 2007 Thakurgaon (Bangladesh) 7 3 43 
Mar 2007 Kushtia, Pabna, Natore (Bangladesh 8 5 13 
April 2007 Nadia (India) 5 5 101 
Feb 2008 Manikgonj (Bangladesh) 4 4 101 
Apr 2008 Rajbari and Faridpur (Bangladesh 7 5 71 
Jan 2009 Gaibandha, Rangpur and Nilphamari 
(Bangladesh) 
3 0 0 
Jan 2009 Rajbari (Bangladesh) 1 1 101 
Feb–Mar 2010 Faridpur, Rajbari, Gopalganj, Madaripur 
(Bangladesh) 
16 14 87.5 
Jan–Feb 2011 Lalmohirhat, Dinajpur, Comilla, Nilphamari 
and Rangpur (Bangladesh) 
44 40 91 
Feb 2012 Joypurhat, Rajshahi, Natore, Rajbari and 
Gopalganj (Bangladesh) 
12 10 83 
Jan–Feb 2013 Gaibandha, Natore, Rajshahi, Naogaon, 
Rajbari, Pabna, 
Jhenaidah, Mymensingh (Bangladesh) 
12 10 83 
Total  292 221 75.7 
 
The above table 1 shows the detailed account of 
the first NiV outbreak in India (Siliguri, West 
Bengal) during 2001 has been published in 
various reports [14, 15]. An outbreak of acute 
encephalitis occurred in Siliguri (West Bengal) 
town of India between the months of January 31 
and February 23, 2001. A total no. of 66 possible 
human cases out of which 45 deaths were 
reported. Later, the clinical material obtained 
during the Siliguri outbreak was retrospectively 
analyzed for evidence of NiV infection [13]. 
Analysis of the limited sequence data suggested 
that the NiV strains associated with the outbreak 
were more closely related to NiV isolated in 
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Bangladesh than to NiV isolated in Malaysia 
[14]. 
In the Malaysian outbreak, pigs were the 
intermediate hosts. NiV was isolated from fruit 
bats in Malaysia [16] 
Fruit bats with antibodies to NiV were captured 
in the outbreak areas of Bangladesh but no 
intermediate animal host was identified. In 
Bangladesh, NiV might have been transmitted to 
humans by direct contact with bats or indirectly 
by contact with material contaminated by bats. 
Person-to-person spread was also noted during 
the 2004NiV outbreak in Faridpur, Bangladesh 
[17, 18]. The range of Pteropus giganteus, one of 
the flying foxes commonly found in South Asia 
[19] includes West Bengal. Therefore, the range 
of the proposed natural reservoir for NiV 
extends into northeastern India. Since the 
geographical features of West Bengal are similar 
to those of Bangladesh, environmental 
circumstances that favor transmission of NiV to 
humans would also likely be same in West 
Bengal. Many of the epidemiologic features of 
the outbreak in Siliguri were similar to those of 
the recent NiV outbreaks in Bangladesh. 
Analysis of the limited sequence data suggested 
that the NiV strains associated with the outbreak 
were more closely related to NiV isolated in 
Bangladesh than to NiV isolated in Malaysia. 
These data extend the previous observation that 
viruses circulating in different areas have unique 
genetic signatures and suggest that these strains 
may haveco-evolved within local natural 
reservoirs [20, 21]. After 2001, the second NiV 
outbreak was reported in West Bengal in India in 
2007. Between 11 and 28 April 2007, Krishnan 
[22] reported 30 cases of fever with acute 
respiratory distress and/or neurological 
symptoms from Nadia district of West Bengal in 
India. The cases presented mainly with fever, 
headache and bodyache with a few cases having 
episodes of vomiting, disorientation, respiratory 
distress. Five cases ended fatally within 3–10 
days of onset. However, Arankalle et al. [23] 
investigated the same outbreak and stated that 
similar other cases had not been reported from 
the village or the surrounding area, thus showed 
case fatality (5/5) as 100 %. They also amplified 
full-genome sequence of NiV (18252 nt) from 
lung tissue that showed 99.2 % nucleotide and 
99.8 % amino acid identity with the Bangladesh-
2004 isolate, suggesting a common source of the 
virus. 
NIPAH VIRUS DISEASE IN HUMANS 
Human Nipah virus (NiV) infection was first 
recognized in a large outbreak of 276 reported 
cases in peninsular Malaysia and Singapore from 
September 1998 through May 1999 [24-26]. 
Most cases had contact with sick pigs [27]. 
Cases presented primarily with encephalitis; 
39% died [26,28]. Autopsy studies noted diffuse 
vasculitis most prominently involving the central 
nervous system with intense immuno staining of 
endothelial cells with anti-Nipah virus 
hyperimmune serum [24]. The virus, a member 
of the recently designated genus Henipavirus, 
within the family Paramyxoviridae, was first 
isolated from a patient from Sungai Nipah 
village [24,26]. The human outbreak of Nipah 
infection ceased after widespread deployment of 
personal protective equipment to people 
contacting sick pigs, restriction on livestock 
movements, and culling over 900,000 pigs [29]. 
Large fruit bats of the genus Pteropus appear to 
be the natural reservoir of NiV. In Malaysia the 
sero prevalence of neutralizing antibodies to 
NiV in colonies of Pteropus vampyrus and P. 
hypomelanus ranged from 7 – 58% [30,31]. 
Antibodies against henipaviruses have been 
identified in Pteropus bats wherever they have 
been tested including Cambodia, Thailand, 
India, Bangladesh and Madagascar [32-36]. NiV 
was isolated from urine specimens collected 
underneath a P. hypomelanus roost and from 
partially eaten fruit dropped during feeding 
activity in Malaysia [27], from urine collected 
underneath a P. lylei roost in Cambodia [32], 
and from saliva and urine of P. lylei in Thailand 
[33]. Experimental infection of Pteropus bats 
with NiV does not cause illness in the bats [38]. 
Surveys of rodents and other animals have not 
identified other wildlife reservoirs for NiV [30, 
35]. Over 50 species of Pteropus bats live in 
South and South East Asia [39]. P. giganteus, the 
only Pteropus species found in Bangladesh, is 
widely distributed across the country and 
frequently has antibody to NiV [35, 40]. 
The growth of large intensively managed 
commercial pig farms in Malaysia with fruit 
trees on the farm created an environment where 
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bats could drop partially eaten fruit 
contaminated with NiV laden bat saliva into pig 
stalls. The pigs could eat the fruit, become 
infected with NiV, and efficiently transmit virus 
to other pigs because of the dense pig population 
on the farms, frequent respiratory shedding of 
the virus among infected pigs [41], and the pigs' 
high birth rate that regularly brought newly 
susceptible young pigs into the population at risk 
[42]. 
Clinical disease 
Nipah virus infected patients generally present 
with fever and altered mental status; 
neurological signs of disease progress over time, 
leading to coma and ultimately death. [43-45]  
Although neurological disease is the main 
complication with Nipah virus infection, 
respiratory disease also occurs to varying 
degrees: during the 1998-1999 outbreak in 
Malaysia and Singapore ~25% of cases 
presented with respiratory disease, vs. 69% of 
cases in Bangladesh [46]. The case-fatality ratio 
in Nipah virus infected people is high 40% 
during the outbreak in Malaysia and Singapore; 
in Bangladesh and India the overall case-fatality 
ratio is 70%, but may be 100% in individual 
outbreaks. Late-onset or relapse encephalitis has 
been observed; in one case this late-onset 
encephalitis occurred 11 years after the initial 




Figure 1: Pathways transmission of Nipah Virus 
All available data on histopathological changes 
in humans infected with Nipah virus were 
obtained in a single study performed during the 
Nipah virus outbreak in Malaysia and Singapore. 
The main site of infection in Nipah virus patients 
was the endothelium. Systemic vasculitis was 
observed in almost all patients, mainly involving 
blood vessels in the CNS, but blood vessels in 
lungs, heart and kidneys were also affected [50]. 
Perivascular cuffing, thrombosis, necrosis and 
endothelial cell syncytia were also observed. In 
the CNS, neurons were clearly infected with 
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Nipah virus as indicated by immune-
histochemistry. In the lungs, fibrinoid necrosis 
was noted in alveoli adjacent to small vessels 
with vasculitis, and alveolar hemorrhage and 
pulmonary oedema were observed frequently. In 
the spleens of many cases, acute necrotizing 
lesions in the periarteriolar sheaths and lymphoid 
depletion were observed. In the kidneys of one 
third of patients focal glomerular fibrinoid 
necrosis was seen [50]. 
Figure 1 is illustrating the pathways transmission 
of Nipah Virus, how it transmits from one 
organism to another. Nipah virus (NiV) infection 
is a newly emerging zoonotic disease that causes 
severe disease in both animals and humans. The 
natural host of the virus are fruits, bats of the 
Pteropodidae Family, Pteropus genus NiV was 
first identified during an outbreak of the disease 
that took place in Kampung Sungai Nipah, 
Malaysia in 1998. In the above figure it can be 
seen that the transmission occurs from flying 
bats to trees, as the bats sit on the trees infect the 
fruits and parts of the plants and from there it 
transfers directly into animals as they live on the 
trees. This is possible as the animals feeds on the 
fruits of the trees and then comes in direct 
contact with humans which makes it possible for 
the virus to be transmitted from the infected 
animals to humans, hence zoonosis. 
The growth of large intensively managed 
commercial pig farms in Malaysia with fruit 
trees on the farm created an environment where 
bats could drop partially eaten fruit contaminated 
with NiV laden bat saliva into pig stalls. The pigs 
could eat the fruit, become infected with NiV, 
and efficiently transmit virus to other pigs 
because of the dense pig population on the farms, 
frequent respiratory shedding of the virus among 
infected pigs [49] and the pigs' high birth rate 
that regularly brought newly susceptible young 
pigs into the population at risk [50] 
ANIMAL MODELS OF NIPAH VIRUS 
DISEASE: 
Nipah virus host species: flying foxes and pigs 
Experimental Nipah virus inoculations have been 
performed in some of its natural reservoir 
species, grey-headed fruit bats (P. poliocephalus) 
and large flying foxes (P. vampyrus), and in the 
intermediate host, domestic pigs.  
Virus shedding upon inoculation of large flying 
foxes was minimal, with viral RNA detected in 
only two swabs from one out of eight infected 
bats (one throat and one rectal swab). Nipah 
virus RNA was detected in the urine of one of 17 
inoculated grey-headed flying foxes, but not in 
any of the conjunctival, tonsillar, nasal or rectal 
swabs collected from these animals. Nipah virus 
isolation from bat tissues was rare and was only 
successful on day 7 after inoculation. Although 
some histopathological lesions were observed in 
inoculated bats, there was no detection of Nipah 
virus antigen associated with these lesions, so 
whether these lesions were caused by Nipah 
virus replication remains inconclusive. All 
inoculated bats sera converted, although virus 
neutralizing titres were generally low [51,52]. 
Experimental Nipah virus inoculations have also 
been performed in its intermediate, amplifying 
host, pigs. Oral inoculation of pigs did not result 
in clinical disease, but animals did develop a 
neutralizing antibody response. 
Subcutaneous as well as a combination of 
intranasal, ocular and oral inoculation resulted in 
neurological and respiratory disease, albeit not in 
all inoculated animals [53,54].  The most 
common histopathological findings in pigs were 
meningitis and encephalitis; in pigs with severe 
clinical disease broncho interstitial pneumonia, 
systemic vasculitis and focal necrosis of spleen 
and lymph nodes were also observed. Viral 
antigen was detected in endothelial and smooth 
muscle cells of the brain, lungs and lymphoid 
system. Neurons, glial cells, epithelial cells of 
the upper as well as lower respiratory tract were 
also positive by immune histochemistry [53, 54]. 
Figure 2 below is showing the transmission of 
Nipah Virus from infected animals to humans. 
Nipah virus (NiV) is a zoonotic virus (it is 
transmitted from animals to humans) and can 
also be transmitted through contaminated food or 
directly between people. In infected people, it 
causes a range of illnesses from asymptomatic 
(subclinical) infection to acute respiratory illness 
and fatal encephalitis.  "Its is a zoonotic disease 
(spreads from animals to humans) and its 
transmission can happen through infected bats by 
their bite or indirectly by consuming fruits like 
mangoes or date palm sap contaminated by their 
saliva, close contact with infected pigs or 
patients of Nipah virus infection. Human who 
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have direct contact with infected fruit bats or 
infected pigs is the usual way an outbreak 
begins. However, consumption of raw date palm 
sap contaminated with bat faeces is another 
common way to get the disease. Human-to-
human transmission occurs during close contact 
between family members and/or medical 
caregivers. 
 
Figure 2: Transmission from infected Animals to Humans 
Syrian hamsters 
Upon inoculation with Nipah virus, Syrian 
hamsters developed respiratory and neurological 
disease; higher inoculum doses resulted in rapid 
development of lethal respiratory disease and 
lower doses resulted in the development of 
neurological signs. Several studies have shown 
that the route of inoculation has an effect on the 
development of disease, with disease 
progressing more rapidly and time to death being 
shorter upon intraperitoneal inoculation as 
compared to intranasal inoculation. Like human 
patients, the main histopathological finding in 
Syrian hamsters infected with Nipah virus was 
systemic vasculitis. Moreover, animals 
developed encephalitis and neurons in the CNS 
were clearly infected; viral antigen was detected 
by immunohistochemistry and inclusion bodies 
were observed that were shown to be 
nucleoprotein aggregates by electron 
microscopy. In hamsters that developed severe 
respiratory disease, usually upon intranasal 
inoculation with a high inoculum dose, rhinitis 
was observed, with virus replicating in the 
respiratory as well as olfactory epithelium, 
bronchointerstitial pneumonia developed in the 
lungs of these animals [54]. 
Ferrets 
Ferrets inoculated oronasally with Nipah virus 
developed respiratory as well as neurological 
signs of disease. Systemic vasculitis was present 
in infected ferrets. Histologically, the upper 
respiratory tract, with rhinitis, tonsillitis and 
nasopharyngitis, as well as the lower respiratory 
tract, with necrotizing bronchointerstitial 
pneumonia, were affected; focal necrosis was 
detected in the spleen [55, 56]. Encephalitis was 
not detected, but nonsuppurative meningitis 
occurred in a subset of animals and viral antigen 
was detected in brain endothelial cells and 
meninges, and occasionally in neurons and glial 
cells close to infected endothelium. 
Cats 
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Cats inoculated with Nipah virus subcutaneously 
or intranasally and orally developed signs of 
respiratory disease. Histologically, cats 
developed bronchointerstitial pneumonia and, in 
some animals, meningitis [53, 57]. 
Methods 
Case Definition and Clinical Sample 
Collection 
A team of physicians and epidemiologists from 
the National Institute of Virology, Pune, India, 
along with local public health authorities, visited 
Siliguri. Investigations were conducted with the 
assistance of health authorities from West 
Bengal State and staff from the North Bengal 
Medical College Hospital. Medical records of 
patients who were hospitalized during the study 
period were examined, and their family members 
or caretakers were interviewed. Areas of the 
town in which cases occurred and the houses of 
patients who died were visited. Contacts and 
family members of patients who died were also 
interviewed. A broad working case definition 
was used for case detection. The case definition 
evolved over the course of the outbreak on the 
basis of information from case-patients admitted 
to different hospitals, review of the line list of 
patients, and interviews with contacts in the 
community. A suspected patient was one >15 
years of age with acute. onset of high-grade 
fever and headache. A probable patient was one 
>15 years of age who had high-grade fever and 
altered sensorial and encephalitis of unknown 
origin. Blood samples were available for 18 
hospitalized patients and for 13 family contacts 
of patients who died 2–3 weeks earlier. Six urine 
samples (5 samples had corresponding serum 
samples) were also collected [11] 
Serologic Testing 
State health authorities conducted laboratory 
tests to rule out malaria and bacterial infections. 
Serologic tests to detect infection by Japanese 
encephalitis virus, West Nile virus, measles 
virus, dengue virus, Leptospira spp., and 
hantavirus were carried out at the National 
Institute of Virology. Serum samples were 
gamma-irradiated at the Centers or Disease 
Control and Prevention (CDC) before being 
tested for immunoglobulin G (IgG) and IgM 
antibodies to NiV and measles by enzyme-linked 
immunosorbent assay (ELISA), as previously 
described. Briefly, inactivated antigens for these 
ELISAs were prepared from gamma (60Co)-
irradiated NiV-infected or mock-infected Vero 
E6 cells. Serum samples were tested in 4-fold 
dilutions from 1:100 to 1:6,400. Samples were 
considered positive for the IgM assay if the sum 
of the adjusted optical densities (OD) from all of 
the dilutions (OD from infected antigen well 
minus OD from the mock-infected antigen) was 
>0.75 through the entire dilution series, and the 
titer was >1:400. Similarly, samples were 
considered positive for IgG if the sum for the 
adjusted OD from all the dilutions was >0.90 
through the entire dilution series, and the titer 
was >1:400 [11]. 
Case Identification and Sample Collection 
We conducted this study in 3 Nipah surveillance 
hospitals at Faridpur, Rajshahi, and Rangpur, 
Bangladesh, during December 2013–April 2014. 
Surveillance physicians identified patients 
admitted with encephalitis, defined as fever or 
history of fever with axillary temperature 
>38.5°C (101.3°F) and altered mental status, 
new onset of seizures, or new neurologic deficit 
and collected blood and oral swab samples. 
Because of resource constraints, surface 
sampling for all encephalitis cases was not 
possible; therefore, a research assistant swabbed 
hospital surfaces near encephalitis patients with 
a history of consuming raw date palm sap, 
contact with another encephalitis patient, or 
both. Occasionally, physicians from other nearby 
hospitals reported suspected Nipah case-patients 
to public health authorities. These patients also 
had biological samples collected for laboratory 
testing but were not included in the surface 
sampling study [11]. 
Blood samples were centrifuged at the local 
government health facility, and the separated 
serum was stored and transported to the Institute 
of Epidemiology Disease Control and Research 
laboratory in a liquid nitrogen dry shipper (–
150°C) and then stored at –20°C until testing. 
From each patient, 1 oral swab was collected in 
1 mL of nucleic acid extraction lysis buffer 
every consecutive day for 7 days, until hospital 
discharge or death, whichever occurred first 
[11].  
Dhiraj et al.                           International Journal of Innovative Science and Technology                             ISSN: 2455 - 9946 
 
© 2018 IJIST Publishing Group                2018; 3(2), 5-14 Page 12 
A research assistant collected 1 swab sample 
from up to 5 areas near each patient: the wall 
beside patient bed, bed rail, bed sheet, clinical 
record file, and multipurpose towel used by 
family caregivers for cleaning patient secretions, 
drying hands, and other caregiving purposes. 
The research assistant collected surface swab 
samples at least 12 hours after the patient was 
admitted to the hospital. With 1 sterile rayon 
swab stick per surface, the research assistant 
swabbed the area of the wall in contact with the 
bed 45 cm high from the level of the bed sheet; 
all surfaces of the bed rail in the area near the 
patient’s head; half of the bed sheet where the 
patient’s head was, including underneath the 
patient; front and back covers of the patient file; 
and both sides of the multipurpose towel. Not all 
patients had a wall or bed rail near them because 
some patients were cared for on the floor and 
some were away from the walls. One swab 
sample per surface area was collected in separate 
cryovials with 1 mL of nucleic acid extraction 
lysis buffer (bioMérieux, Marcy-l’Étoile, 
France). The vials were kept in a cool box 
maintaining a temperature of 2°–8°C for up to 
30 min after collection and then were placed in a 
liquid nitrogen dry shipper for storage and 
transportation [11]. 
Community Investigation 
An investigation team visited the communities 
of encephalitis patients identified at surveillance 
hospitals who had NiVIgM in serum to identify 
any other associated encephalitis cases. The 
team interviewed identified encephalitis patients 
and their caregivers using a structured 
questionnaire. Identified patients were asked 
about the nature of their contact with 
hospitalized patients (i.e., touching, being in the 
same room, feeding, sharing a bed, or cleaning 
body secretions) to find evidence of person-to-
person transmission. The team also collected 
blood from the encephalitis patients identified in 
the community investigation [11]. 
CONCLUSION 
An infectious disease outbreak in south India 
that has left at least 16 people dead has brought 
the world’s attention to a little-known health 
threat: the Nipah virus. An emerging zoonotic 
virus whose natural host is the Pteropus fruit bat, 
Nipah virus was first recognised in the late 
1990s when an outbreak in pigs in Malaysia and 
Singapore moved to humans, killing 106 people. 
Since then, interest in Nipah virus has remained 
limited to small research communities and 
affected countries. Annual outbreaks occur in 
Bangladesh, where humans are exposed through 
consumption of the sap of date palm trees 
contaminated by infected bats. Worryingly, 
Nipah virus can also be transmitted from human 
to human, as in the current south India outbreak, 
with most cases occurring in family members or 
health workers caring for individuals sick with 
the high fever, vomiting, and breathing 
difficulties characteristic of infection. Severe 
cases can lead to respiratory syndrome, 
encephalitis, and death—the case fatality rate 
may be up to 75%. There is no cure, vaccine, or 
specific treatment—supportive care is the most 
that can be offered to affected individuals. Nipah 
virus infection has so far been limited to 
countries in south and east Asia, where 600 
cases have been reported between 1998 and 
2015, according to WHO. And all the cases was 
caused by the transmission from the bats to 
plants fruits and from that it was transferred to 
the pigs then it come in contact with the humans 
and then the human suffers from it. Mostly in 
humans it is transferred by the infected fruits 
which is been consumed by the humans due to 
the lack of awareness about the infected fruits 
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